K081345

Substantially Equivalent for Some Indications

AXP PLATFORM MARROW XPRESS SYSTEM MODEL 8-5137, 8-5138, 8-5139, 8-5140 (PRIMARY)

Applicant
Thermogenesis Corp.
Product code
JQC
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent for Some Indications
Clearance type
Abbreviated
Location
Rancho Cordova, CA, US
Download summary PDF View on FDA.gov ↗

Adverse events under product code JQC

product code JQC
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.